Literature DB >> 14290417

MELANOMA OF THE GENITOURINARY TRACT.

T DASGUPTA, H GRABSTALD.   

Abstract

Keywords:  MELANOMA; NEOPLASM DIAGNOSIS; NEOPLASM METASTASIS; PROGNOSIS; SURGERY, OPERATIVE; UROGENITAL NEOPLASMS

Mesh：

Year:  1965        PMID： 14290417     DOI： 10.1016/s0022-5347(17)63838-2

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  8 in total

1.  Multiple metastases of a malignant cutaneous melanoma in the cavitary system of the upper urinary tract.

Authors:  P Török; T Kiss
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

2.  Melanoblastoma of the female urethra.

Authors:  P Novák; M Strmiska
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

Review 3.  Melanoma of the female urethra.

Authors:  Dino Papeš; Silvio Altarac
Journal:  Med Oncol       Date:  2012-12-18       Impact factor: 3.064

Review 4.  Primary malignant melanoma of the female urethra: a case report.

Authors:  F Aragona; G Maio; R Piazza; R Salmaso
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

5.  A Case Report of Primary Recurrent Malignant Melanoma of the Urinary Bladder.

Authors:  Hong Truong; Debasish Sundi; Nikolai Sopko; Dongmei Xing; Evan J Lipson; Trinity J Bivalacqua
Journal:  Urol Case Rep       Date:  2013-11-12

Review 6.  Melanoma of the urinary bladder: a review of the literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Surg Res Pract       Date:  2014-01-12

7.  Malignant melanoma revealed by testicular metastasi.

Authors:  Marie Dusaud; Lucille Adjadj; Alexandre Debelmas; Jean Baptiste Souraud; Xavier Durand
Journal:  Int J Surg Case Rep       Date:  2015-05-21

8.  Metastatic malignant melanoma of the urinary bladder: Case report and literature review.

Authors:  Anna Paterson; Michał Sut; Asheesh Kaul; Vincenzo Altieri; Fraser Mutch; Jenish Patel; Harbinder Sharma
Journal:  Cent European J Urol       Date:  2012-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.